These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7076344)
1. The influence of a single dose of vasopressin analogs on human renal potassium excretion. Nádvorníková H; Schück O Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):155-8. PubMed ID: 7076344 [TBL] [Abstract][Full Text] [Related]
2. [Experiences with the intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP)--effect of one time parenteral and intranasal applications]. Tuschy U; Meinhold J; Szeszat S Z Gesamte Inn Med; 1983 Aug; 38(16):450-2. PubMed ID: 6636913 [TBL] [Abstract][Full Text] [Related]
3. Effects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin. Bakos P; Ponec J; Lichardus B Gen Physiol Biophys; 1984 Aug; 3(4):297-305. PubMed ID: 6094299 [TBL] [Abstract][Full Text] [Related]
4. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus. Walker LA; Frölich JC J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662 [TBL] [Abstract][Full Text] [Related]
5. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man. Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263 [TBL] [Abstract][Full Text] [Related]
6. The urinary excretion of selenium in sheep treated with a vasopressin analogue. Leng L; Boldizárová K; Faix S; Kovác G Vet Res; 2000; 31(5):499-505. PubMed ID: 11050745 [TBL] [Abstract][Full Text] [Related]
7. Comparison of antidiuretic and natriuretic effects of [8-lysine]vasopressin and [8-D-arginine]deaminovasopressin in conscious rats. Skopková J; Hrbas R; Barth T Endocrinol Exp; 1981; 15(2):129-38. PubMed ID: 6973460 [TBL] [Abstract][Full Text] [Related]
8. Detection of renal impairment in cases of chronic abuse of analgesics by administration of desamino-D-arginine vasopressin. Wambach G; Bönner G; Kleinpass H; Dopatka A; Kaufmann W Arzneimittelforschung; 1989 Mar; 39(3):387-90. PubMed ID: 2569306 [TBL] [Abstract][Full Text] [Related]
9. Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients. Laczi F; Valkusz Z; Lászlo FA; Wagner A; Járdánházy T; Szász A; Szilárd J; Telegdy G Psychoneuroendocrinology; 1982; 7(2-3):185-93. PubMed ID: 7178372 [TBL] [Abstract][Full Text] [Related]
10. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in a simple test of renal concentrating ability]. Tuschy U; Szeszat S; Rindfleisch U Z Gesamte Inn Med; 1984 Jun; 39(11):265-8. PubMed ID: 6475171 [TBL] [Abstract][Full Text] [Related]
11. Effect of DDAVP on plasma renin activity in man. Radó JP; Boer P Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):307-10. PubMed ID: 489197 [TBL] [Abstract][Full Text] [Related]
12. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin. Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082 [TBL] [Abstract][Full Text] [Related]
13. The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in older men: a pilot study. Johnson TM; Burridge A; Issa MM; Miller M; Tang T; Ouslander JG J Am Geriatr Soc; 2007 Apr; 55(4):562-9. PubMed ID: 17397435 [TBL] [Abstract][Full Text] [Related]
14. [Renal excretion of potassium in individuals with stabilized function of a transplanted kidney]. Schück O; Stríbrná J; Teplan V; Vítko S; Matl I; Skibová J; Stollová M Vnitr Lek; 1998 Jun; 44(6):315-9. PubMed ID: 9820052 [TBL] [Abstract][Full Text] [Related]
15. [(Na-K) ATPase activity and corticopapillary osmotic gradient in the kidney of rats with hereditary hypothalamic diabetes insipudus after administration of 1-deamino-8-arginine-vasopressin (DDAVP)]. Michajlovskij N; Ponec J; Dzurba A; Lichardus B Bratisl Lek Listy; 1980 Jun; 73(6):741-8. PubMed ID: 6249465 [No Abstract] [Full Text] [Related]
16. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus. Laczi F; Mezei G; Julesz J; Lázló FA Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552 [TBL] [Abstract][Full Text] [Related]
17. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration. Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972 [TBL] [Abstract][Full Text] [Related]
19. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2. Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526 [TBL] [Abstract][Full Text] [Related]
20. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985. Decaux G J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]